Prestige Consumer Healthcare Inc. | Mid-cap | Healthcare
$64.99
0.60%
| Prestige Consumer Stock Comparison:
Prestige Consumer vs ZoetisPrestige Consumer vs Haleon Plc - ADRPrestige Consumer vs Elanco Animal HealthPrestige Consumer vs Regencell BiosciencePrestige Consumer vs Alkermes plcPrestige Consumer vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 296.5M
Gross Profit 170.0M 57.34%
Operating Income 100.9M 34.03%
Net Income 50.1M 16.91%

Balance Sheet Metrics

Total Assets 3.4B
Total Liabilities 1.6B
Shareholders Equity 1.8B
Debt to Equity 0.85

Cash Flow Metrics

Operating Cash Flow 47.5M
Free Cash Flow 58.4M

Revenue & Profitability Trend

Prestige Consumer Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.1B1.1B1.1B1.1B943.4M
Cost of Goods Sold i503.3M500.9M502.4M466.2M395.9M
Gross Profit i634.5M624.4M625.3M620.6M547.5M
Gross Margin % i55.8%55.5%55.4%57.1%58.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i263.9M259.5M252.4M264.8M223.7M
Other Operating Expenses i-----
Total Operating Expenses i263.9M259.5M252.4M264.8M223.7M
Operating Income i349.2M342.4M347.8M331.0M299.8M
Operating Margin % i30.7%30.4%30.8%30.5%31.8%
Non-Operating Items
Interest Income i-----
Interest Expense i47.6M67.2M69.2M64.3M82.3M
Other Non-Operating Income-17.4M756.0K-372.6M-4.2M-13.4M
Pre-tax Income i284.2M276.0M-93.9M262.5M204.1M
Income Tax i69.6M66.7M-11.6M57.1M39.4M
Effective Tax Rate % i24.5%24.2%0.0%21.7%19.3%
Net Income i214.6M209.3M-82.3M205.4M164.7M
Net Margin % i18.9%18.6%-7.3%18.9%17.5%
Key Metrics
EBITDA i374.5M373.9M378.1M362.0M331.4M
EPS (Basic) i-$4.21$-1.65$4.09$3.28
EPS (Diluted) i-$4.17$-1.65$4.04$3.25
Basic Shares Outstanding i-49757000498890005025900050210000
Diluted Shares Outstanding i-49757000498890005025900050210000

Income Statement Trend

Prestige Consumer Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i97.9M46.5M58.5M27.2M32.3M
Short-term Investments i-----
Accounts Receivable i202.0M185.0M183.4M159.0M114.7M
Inventory i147.7M138.7M162.1M120.3M115.0M
Other Current Assets8.4M13.1M4.1M6.4M7.9M
Total Current Assets i448.3M375.0M391.7M293.3M269.8M
Non-Current Assets
Property, Plant & Equipment i53.3M12.8M19.1M27.2M32.7M
Goodwill i3.4B3.4B3.4B3.9B3.6B
Intangible Assets i2.3B2.3B2.3B2.7B2.5B
Long-term Investments-----
Other Non-Current Assets3.3M5.7M3.0M3.3M2.9M
Total Non-Current Assets i3.0B2.9B3.0B3.4B3.2B
Total Assets i3.4B3.3B3.4B3.7B3.4B
Liabilities
Current Liabilities
Accounts Payable i18.9M39.0M62.7M55.8M46.0M
Short-term Debt i8.5M6.2M9.8M9.1M8.4M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i106.6M117.0M160.7M143.4M122.1M
Non-Current Liabilities
Long-term Debt i1.0B1.1B1.4B1.5B1.5B
Deferred Tax Liabilities i419.6M403.6M380.4M444.9M434.0M
Other Non-Current Liabilities5.4M9.2M8.2M7.5M8.6M
Total Non-Current Liabilities i1.5B1.5B1.7B1.9B1.9B
Total Liabilities i1.6B1.7B1.9B2.1B2.1B
Equity
Common Stock i560.0K555.0K548.0K544.0K540.0K
Retained Earnings i1.6B1.3B1.1B1.2B1.0B
Treasury Stock i277.2M219.6M189.1M133.6M130.7M
Other Equity-----
Total Shareholders Equity i1.8B1.7B1.4B1.6B1.4B
Key Metrics
Total Debt i1.0B1.1B1.4B1.5B1.5B
Working Capital i341.7M258.0M231.0M149.8M147.7M

Balance Sheet Composition

Prestige Consumer Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i214.6M209.3M-82.3M205.4M164.7M
Depreciation & Amortization i30.2M30.7M32.6M32.1M30.2M
Stock-Based Compensation i11.2M14.0M12.4M9.0M8.5M
Working Capital Changes i-53.6M-15.4M-66.9M-22.0M12.5M
Operating Cash Flow i227.2M273.1M-153.8M245.4M238.8M
Investing Activities
Capital Expenditures i-8.2M-9.6M-7.8M-9.6M-22.2M
Acquisitions i-9.2M-10.6M-3.8M-246.9M0
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-17.5M-20.1M-15.4M-256.3M-22.2M
Financing Activities
Share Repurchases i-51.5M-25.0M-50.0M0-11.9M
Dividends Paid i-----
Debt Issuance i000597.0M600.0M
Debt Repayment i-139.5M-227.8M-157.8M-687.6M-866.4M
Financing Cash Flow i-196.9M-259.1M-213.2M-99.6M-352.3M
Free Cash Flow i243.3M239.4M221.9M250.3M213.4M
Net Change in Cash i12.8M-6.1M-382.4M-110.5M-135.7M

Cash Flow Trend

Prestige Consumer Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.92
Forward P/E 16.12
Price to Book 2.07
Price to Sales 3.33
PEG Ratio 16.12

Profitability Ratios

Profit Margin 18.86%
Operating Margin 34.03%
Return on Equity 12.30%
Return on Assets 6.50%

Financial Health

Current Ratio 4.20
Debt to Equity 56.91
Beta 0.43

Per Share Data

EPS (TTM) $4.29
Book Value per Share $37.06
Revenue per Share $22.89

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
pbh3.8B17.922.0712.30%18.86%56.91
Zoetis 65.3B25.3613.1452.77%27.83%137.01
Haleon Plc - ADR 43.6B21.445.449.38%13.81%53.41
Elanco Animal Health 8.9B20.411.326.83%9.68%62.13
Regencell Bioscience 6.6B-960.00-47.77%0.00%0.01
Alkermes plc 4.8B14.032.9523.94%23.15%4.47

Financial data is updated regularly. All figures are in the company's reporting currency.